Depression Clinical Trials in Philadelphia, PA

50 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
Clinical Trial for Integrated Care to Help At Risk Teen (iCHART) Intervention	N/A	University of Pittsburgh	<1 mi
A Study of Brenipatide in Adult Participants With Major Depressive Disorder	Phase 3	Eli Lilly and Company	<1 mi
Disentangling the Role of Depression in Hypersomnia	—	University of Pennsylvania	<1 mi
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)	N/A	Abbott Medical Devices	<1 mi
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.	Phase 2	LB Pharmaceuticals Inc.	<1 mi
Taking Action for College Students	N/A	Temple University	<1 mi
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)	Phase 2	atai Therapeutics, Inc.	<1 mi
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder	Phase 3	Intra-Cellular Therapies, Inc.	<1 mi
Get ActivE Study for At-risk Youth	N/A	University of Pittsburgh	<1 mi
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)	Phase 3	Definium Therapeutics US, Inc.	<1 mi
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms	Phase 3	Janssen Research & Development, LLC	<1 mi
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression	N/A	LivaNova	<1 mi
RISE Versus Advocacy-based Enhanced Care as Usual for Patients Experiencing IPV	N/A	Boston University	<1 mi
Neurofeedback to Treat Depression - 2	N/A	University of Pennsylvania	<1 mi
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	<1 mi
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	<1 mi
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder	Phase 3	Cybin IRL Limited	<1 mi
Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Ketamine	Early 1	University of Pennsylvania	<1 mi
Antidepressant Adherence for Depressed Adults in Primary Care	N/A	University of Pennsylvania	<1 mi
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder	Phase 2	Syndeio Biosciences, Inc	<1 mi
Improving Mood for Adolescents Through Teaming With End-Users in Routine Care (The iMATTER Project)	N/A	Children's Hospital of Philadelphia	<1 mi
Transdiagnostic Sleep and Circadian Intervention + Bright Light in Adolescents With Elevated Depression (TranS-C+BL)	N/A	University of Pittsburgh	<1 mi
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"	Phase 3	Cybin IRL Limited	<1 mi
Healing at Home 2.0 - Enhanced Chat Tool for Lowering Postpartum Depression	N/A	University of Pennsylvania	<1 mi
Postpartum Care in the NICU (PeliCaN) Transitions	N/A	University of Pennsylvania	<1 mi
Evaluate the Effects of Long-term Use of Psychotropic Medications on Eye Movement Patterns With the Gaize Device	—	Gaize	<1 mi
Evaluation of the PACE/PACENET BHL Clinical Program	—	University of Pennsylvania	<1 mi
Decoding and Modulating Affective Brain States	N/A	University of Pennsylvania	<1 mi
Foundational Programs to Combat Clinician Stress	N/A	Lancaster General Hospital	<1 mi
Triage Survey for Psychiatry Research Eligibility	—	Adams Clinical	<1 mi
Telehealth Collaborative Care Model (CoCM) in Lung Cancer	N/A	Abramson Cancer Center at Penn Medicine	<1 mi
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses	Phase 2	Reunion Neuroscience Inc	<1 mi
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)	Phase 3	Xenon Pharmaceuticals Inc.	7 mi
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms	Phase 4	Axsome Therapeutics, Inc.	7 mi
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)	Phase 3	Xenon Pharmaceuticals Inc.	7 mi
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol	Phase 3	Axsome Therapeutics, Inc.	7 mi
E-Mindfulness Approaches for Living After Breast Cancer	Phase 3	NRG Oncology	8 mi
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression	Phase 2	Draig Therapeutics Ltd	12 mi
Study of ALTO-300 in MDD	Phase 2	Alto Neuroscience	12 mi
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder	Phase 3	Vanda Pharmaceuticals	12 mi
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)	Phase 2	Seaport Therapeutics	12 mi
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response	Phase 2	ACADIA Pharmaceuticals Inc.	14 mi
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder	Phase 3	Janssen Research & Development, LLC	14 mi
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)	Phase 2	Autobahn Therapeutics, Inc.	17 mi
Retrospective Analyses of TrakStar Database	—	Neuronetics	19 mi
Retrospective Analyses of the Greenbrook Database Evaluating Mental Health Treatments	—	Neuronetics	19 mi
Positive Processes and Transition to Health (PATH)	N/A	Case Western Reserve University	36 mi
Linking Affective Dynamics in Response to Daily Stress to Peripheral Vascular Function in Working Age Adults	N/A	University of Delaware	36 mi
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder	Phase 2	Syndeio Biosciences, Inc	48 mi
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder	Phase 3	Xenon Pharmaceuticals Inc.	48 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.